Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Biologics: Targets and Therapy Volume 7, 2013 - Issue

Submit an article Journal homepage

Open access

179

Views

CrossRef citations to date

Altmetric

Review

Tivozanib in the treatment of renal cell carcinoma

Mehmet HepgurDivision of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA

Sarmad SadeghiDivision of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA

Tanya B DorffDivision of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA

David I QuinnDivision of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USACorrespondence[email protected]

Pages 139-148 | Published online: 11 Jun 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Suresh Gopi Kalathil, Katy Wang, Alan Hutson, Renuka Iyer & Yasmin Thanavala. (2020) Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. OncoImmunology 9:1.
Read now

M. Tampellini, C. Sonetto & G. V. Scagliotti. (2016) Novel anti-angiogenic therapeutic strategies in colorectal cancer. Expert Opinion on Investigational Drugs 25:5, pages 507-520.
Read now

Articles from other publishers (2)

Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal & Christopher J. O’Donnell. (2019) Synthetic Approaches to the New Drugs Approved During 2017. Journal of Medicinal Chemistry 62:16, pages 7340-7382.
Crossref

Muhammad Omer Jamil, Amanda Hathaway & Amitkumar Mehta. (2015) Tivozanib: Status of Development. Current Oncology Reports 17:6.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references